| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $293,945,412 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA282437 | Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer | 000 | 3 | NIH | 2/26/2026 | $668,170 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EB036530 | Leveraging Multi-Modal AI for Selective Use of Ultrasound in Breast Cancer Screening | 000 | 2 | NIH | 6/9/2026 | $654,712 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA284604 | Optimizing TCR-CD3 signaling for immunotherapy of cancer | 000 | 3 | NIH | 4/7/2026 | $635,940 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH101377 | Deconstruction of a Neural Circuit for Aggression | 000 | 14 | NIH | 12/2/2025 | $746,458 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA058277 | A comparative evaluation of overdose prevention programs in New York City and Rhode Island | 001 | 4 | NIH | 5/8/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA058277 | A comparative evaluation of overdose prevention programs in New York City and Rhode Island | 000 | 4 | NIH | 2/17/2026 | $1,437,775 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U19AI191396 | Applying Genomics and Omics in Pig to Human Decedent Xenotransplantation | 000 | 2 | NIH | 6/9/2026 | $2,827,991 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30MH143505 | Uncovering the Dynamics of Hippocampal-Neocortical Coupling in Humans and Mice | 000 | 1 | NIH | 4/9/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC023790 | Cortical mechanisms of normal and disordered human speech | 000 | 1 | NIH | 6/26/2026 | $685,327 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA063711 | NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS | 001 | 2 | NIH | 5/25/2026 | $775,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1DA064531 | “GLP-1 Outcomes with people Using Psychoactive Substances (GLOW-UPS): a multi-stage, multi-site trial among persons involved in the criminal-legal system | 001 | 2 | NIH | 7/16/2026 | $1,374,439 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34CA313437 | Development and feasibility testing of a mobile app to deliver an evidence-based intervention targeting financial stress and smoking | 000 | 1 | NIH | 6/26/2026 | $310,185 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23NS146694 | Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children with Neurofibromatosis Type 1 | 000 | 1 | NIH | 1/23/2026 | $247,995 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R56MH139686 | The Role of Long Non-Coding RNA in Response to Stress | 000 | 1 | NIH | 6/9/2026 | $1,694,752 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI202302 | Testing the epigenetic basis and evolutionary generality of bacterial persistence | 000 | 1 | NIH | 7/1/2026 | $254,250 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG090618 | Technologies to probe the biophysical properties of aging cells | 000 | 1 | NIH | 1/23/2026 | $708,137 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P01AI181994 | The Use of the Pig-to-Human Decedent Model to Optimize Future Results in Clinical Xenotransplantation Trials | 000 | 1 | NIH | 4/17/2026 | $2,064,597 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG091450 | A prospective study of viral infections and subsequent risk of Alzheimer’s disease | 000 | 1 | NIH | 1/23/2026 | $712,578 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK143287 | Increasing kidney transplants with stratified kidney allocation: acceptability and impacts | 000 | 1 | NIH | 2/19/2026 | $847,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | DP2AI184743 | Move, Eat, Trap, or Kill: Decoding the molecular logic used by innate immune cells to decide between functional programs | 000 | 1 | NIH | 4/24/2026 | $508,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AG093093 | (Micro)structural Biomarkers of Skeletal Muscle Health Across the Lifespan | 000 | 1 | NIH | 1/9/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DA063565 | Neurobehavioral Mechanisms of Social Behavior and Familial Structure | 000 | 1 | NIH | 3/9/2026 | $1,240,576 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA064979 | A Social Network Approach to Improve HIV Prevention and Substance Use Treatment for People Who Use Drugs | 000 | 1 | NIH | 3/9/2026 | $771,043 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA311706 | SHP2 Signaling from Molecule to Mouse | 000 | 1 | NIH | 6/30/2026 | $684,529 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99DC022956 | Neural Computations Underlying Intensity Perception Across Sensory Systems | 000 | 1 | NIH | 6/12/2026 | $135,972 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R13NS149699 | Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging Findings in AD and ADRD | 000 | 1 | NIH | 5/7/2026 | $10,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R13NS149699 | Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging Findings in AD and ADRD | 000 | 1 | NIH | 5/7/2026 | $10,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG092496 | Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women | 000 | 1 | NIH | 1/27/2026 | $724,813 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL178710 | Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome | 001 | 2 | NIH | 7/17/2026 | $2,202,194 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HD120238 | Strengthening Screening and Referral Systems to Address Early Childhood Obesity Risk | 000 | 2 | NIH | 5/12/2026 | $722,724 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH142698 | Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia | 000 | 1 | NIH | 2/19/2026 | $871,225 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R03CA310697 | MINING OF REVERSE TRANSCRIPTASE INHIBITOR TREATED PATIENT DATA TO IDENTIFY LINE-1 RETROTRANSPOSON ROLE IN HUMAN DISEASES | 000 | 1 | NIH | 7/7/2026 | $169,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31MH143451 | Unraveling Cerebellar Contributions to Schizophrenia Spectrum Disorders: Integrating Function, Structure, and Iron Content | 001 | 1 | NIH | 4/6/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31MH143451 | Unraveling Cerebellar Contributions to Schizophrenia Spectrum Disorders: Integrating Function, Structure, and Iron Content | 000 | 1 | NIH | 4/6/2026 | $50,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 002 | 1 | NIH | 4/13/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 001 | 1 | NIH | 4/13/2026 | $1,260 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 000 | 1 | NIH | 3/30/2026 | $75,520 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES037626 | Nickel exposure disrupts Sp1/ZEB1-dependent transcriptional regulation | 000 | 1 | NIH | 6/23/2026 | $3,234,310 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA310109 | Isoform-Selective Targeting of RAF Kinases with Synthetic Binding Proteins | 000 | 1 | NIH | 7/16/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA307096 | Integrated biologic technologies for selective inhibition of intracellular oncoproteins | 000 | 1 | NIH | 7/16/2026 | $595,993 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00EB035163 | Open-Source Software Tools for Rapid Radiofrequency Coil Modeling and Simulation in MRI | 000 | 3 | NIH | 7/15/2026 | $248,999 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES037346 | Evaluating Health Impacts of NYC Congestion Pricing | 000 | 1 | NIH | 4/27/2026 | $4,128,432 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023803 | Bayesian time warping for data-efficient communication brain-computer interfaces | 001 | 1 | NIH | 4/28/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023803 | Bayesian time warping for data-efficient communication brain-computer interfaces | 000 | 1 | NIH | 4/28/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG080769 | Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study | 001 | 2 | NIH | 4/17/2026 | $377,253 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG080769 | Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study | 000 | 2 | NIH | 3/20/2026 | $239,898 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA307281 | Advancing Clinically Translatable Deep Learning for Prostate Cancer Detection on MRI | 000 | 1 | NIH | 7/16/2026 | $700,171 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA248631 | Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1 | 000 | 6 | NIH | 5/7/2026 | $477,848 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34DA064469 | PrEP-RISE: A Multi-Level PhotoVoice Intervention to Improve PrEP Uptake and Adherence Among Women Who Inject Drugs (WWID) | 000 | 1 | NIH | 5/19/2026 | $256,165 |
|
